Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
75%(6 trials)

Phase Distribution

Ph phase_1
1
13%
Ph phase_2
3
38%
Ph phase_3
3
38%
Ph phase_4
1
13%

Phase Distribution

1

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 23 (37.5%)
Phase 33 (37.5%)
Phase 41 (12.5%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_4

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

NCT03988439
completedphase_2

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

NCT02785159
completedphase_2

Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

NCT02045277
completedphase_2

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

NCT02785172
completedphase_3

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

NCT02462122
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03988439Phase 4

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Completed
NCT02785159Phase 2

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Completed
NCT02045277Phase 2

Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

Completed
NCT02785172Phase 2

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Completed
NCT02462122Phase 3

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Completed
NCT02462070Phase 3

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Completed
NCT02462083Phase 3

Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Completed
NCT03058744Phase 1

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8